Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion type Assertion NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_head.
- NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion description "[To determine the effects of TZDs on AdipoR expression, subcutaneous fat and quadriceps muscle were biopsied in 14 insulin-resistant subjects with type 2 diabetes mellitus after 45 mg pioglitazone or placebo for 21 days.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_provenance.
- NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion evidence source_evidence_literature NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_provenance.
- NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion SIO_000772 17213476 NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_provenance.
- NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion wasDerivedFrom befree-2016 NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_provenance.
- NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_assertion wasGeneratedBy ECO_0000203 NP588029.RADb4TYKh4jj2y7pKSt0H782e6gCweRzujetebcRqIpmA130_provenance.